Goelzer Investment Management, Inc. Organon & Co. Transaction History

Goelzer Investment Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$31.66 - $38.9 $242,768 - $298,285	-7,668 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$30.45 - $39.36 $11,753 - $15,192	-386 Reduced 4.79%	7,668 $268,000
Q4 2021 Feb 11, 2022	SELL	$28.67 - $37.13 $11,926 - $15,446	-416 Reduced 4.91%	8,054 $245,000
Q3 2021 Oct 29, 2021	SELL	$28.63 - $35.64 $183,690 - $228,666	-6,416 Reduced 43.1%	8,470 $278,000
Q2 2021 Aug 12, 2021	BUY	$28.45 - $38.0 $423,506 - $565,668	14,886 New	14,886 $450,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Goelzer Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Goelzer Investment Management, Inc. with notifications on news.